Dlaczego ewolucja zachowała ADHD?

Summary

The video asks whether evolution preserved ADHD because some associated traits may have been useful in particular settings. Its answer is cautious: research offers hypotheses and evidence about pieces of the question, but no proven explanation that ADHD as a whole is an evolutionary advantage. The difficulties associated with ADHD can be significant, and possible evolutionary accounts do not replace diagnosis, treatment, or support.

Exploration versus staying with a known resource

The narrator uses two fictional fruit gatherers, Nora and Eli, to explain the trade-off between exploration and exploitation—continuing to use a familiar resource:

• Staying at a productive tree may pay off at first, but yields can decline.
• Moving to another location may uncover a better resource, but takes time and carries uncertainty.
• The best choice depends on what is available, how quickly conditions change, and how costly it is to move.
• A strategy that helps in one task or environment may be less useful in another. The same person may also use different strategies in different circumstances.

The example illustrates a research problem, not two fixed kinds of people or brain types. A behavior should not be labelled “brilliant” or “impulsive” based only on whether it happens to succeed. Fair comparisons require clear measures and attention to costs as well as rewards.

What the studies suggest—and what they do not

The video describes several kinds of evidence, emphasizing that each measures something different:

• Online foraging game (Barak and colleagues, 2024): In a study of 457 adults, participants chose whether to keep collecting from dwindling sites or travel to new ones. People above a threshold on an ADHD symptom screening measure left sites sooner and earned more rewards per unit of time in the game. This was a result from a narrow task, not evidence that everyone with ADHD is better at gathering resources or handling work and daily life. A screening score is not a diagnosis; the video also notes that the threshold-based comparison was not preregistered and the reward advantage was unexpected.
• Genetic analysis (Demontis and colleagues, 2023): A genomic comparison involving 38,691 people with ADHD and 186,843 controls identified 27 regions with statistically significant associations. This supports a complex, many-factor picture—not the discovery of a single “ADHD gene.” Genetic associations describe differences in probability across populations; they do not determine an individual’s abilities or future.
• DRD4 research among Ariaal men (Eisenberg and colleagues, 2008): The study compared 65 nomadic men with 87 men from a group that had more recently adopted a sedentary lifestyle. The association between the DRD4 7R variant and body measurements varied by context, particularly for lean body mass. The study did not diagnose ADHD or assess hunting ability, and the groups were not randomized. The video cautions against treating contemporary communities as stand-ins for all human ancestors.
• Follow-up research among Ariaal children (Kankle and colleagues, 2025): In 259 children aged 5–10, a preregistered analysis did not reproduce the earlier association with the nutritional measures assessed. The difference between adult and child samples matters; neither finding alone settles the question. The video also notes an association involving family economic circumstances, while stressing that statistical association does not by itself explain a mechanism.
• Genomic-history analysis (Esteller-Cucala and colleagues, 2020): Comparing modern, ancient, and archaic genomic data—primarily European samples—the researchers’ models indicated a decline in the frequency of variants associated with ADHD risk since the Paleolithic and long-term selection against them. The authors considered a possible mismatch between traits and environments, but the result does not establish a simple “hunter versus farmer” explanation. Ancient samples are uneven across places and periods, and genetic data cannot diagnose people who lived in the past.

Taken together, these studies do not show that natural selection deliberately “kept” ADHD because it is beneficial. Evolution is not a conscious designer, and a trait’s persistence does not prove that it is advantageous. Claims about evolutionary history require evidence about reproduction, variation, and environmental change across generations—not just success in a present-day game or an association in a population.

ADHD, support, and how to assess claims

The video stresses that persistent difficulties with attention, impulsivity, or hyperactivity can affect learning, work, relationships, and daily functioning. They are not a moral failing. Recognizing someone’s strengths does not erase their difficulties, and recognizing difficulties does not define their whole person.

The narrator also describes a 14-month clinical trial involving children in five groups. Carefully managed medication and combined treatment had an advantage on many primary symptoms, though results applied to that sample and period—not as a guaranteed outcome or a prescription for everyone. Assessment and treatment choices should be based on an individual’s needs and discussed with qualified professionals. Evolutionary hypotheses do not justify withholding support.

When evaluating claims about ADHD and evolution, the video recommends asking:

1. What was actually measured? A diagnosis, a questionnaire score, a genetic variant, or a specific behavior?
2. Under what conditions was the result obtained?
3. What evidence connects the result to the proposed evolutionary history?

These questions help distinguish a limited finding from a broad claim about human history. The overall message is to investigate possible origins without turning them into either blame or a promise of universal “superpowers.”

Speakers and sources featured

• Speaker: An unnamed narrator.
• Illustrative characters: Nora and Eli, fictional examples rather than research participants or representatives of ADHD groups.
• Research cited in the subtitles: David Barak and colleagues (2024); Ditte Demontis and colleagues (2023; the name is garbled in the auto-captions); Dan Eisenberg and colleagues (2008); Amanda Kankle and colleagues (2025; the name is uncertain in the auto-captions); and Paula Esteller-Cucala and colleagues (2020).
• Clinical trial: A 14-month study of treatment strategies for children with ADHD is mentioned, but the subtitles do not identify its researchers.